We next sought to determine the extent to which the senescence phenotype induced by INX-315 treatment of CDK4/6i–resistant tumors was similar to, or distinct from, CDK4/6i–induced senescence in non-resistant tumor cells. The gene discussed is CDK4; the disease is neoplasm.